DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Olga A. Guryanova, Kaitlyn Shank, Barbara Spitzer, Luisa Luciani, Richard P. Koche, Francine E. Garrett-Bakelman, Chezi Ganzel, Benjamin H. Durham, Abhinita Mohanty, Gregor Hoermann, Sharon A. Rivera, Alan G. Chramiec, Elodie Pronier, Lennart Bastian, Matthew D. Keller, Daniel Tovbin, Evangelia Loizou, Abby R. Weinstein, Adriana Rodriguez Gonzalez, Yen K. LieuJacob M. Rowe, Friederike Pastore, Anna Sophia McKenney, Andrei V. Krivtsov, Wolfgang R. Sperr, Justin R. Cross, Christopher E. Mason, Martin S. Tallman, Maria E. Arcila, Omar Abdel-Wahab, Scott A. Armstrong, Stefan Kubicek, Philipp B. Staber, Mithat Gönen, Elisabeth M. Paietta, Ari M. Melnick, Stephen D. Nimer, Siddhartha Mukherjee, Ross L. Levine

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds